Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 212
-3
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Finding a Cure for Batten Disease

In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

A Modification to Homeopathic Drug Carcinosin

Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

Backer Badge Funded